Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Carin M A Rademaker"'
Autor:
Laurent M A Favié, Floris Groenendaal, Marcel P H van den Broek, Carin M A Rademaker, Timo R de Haan, Henrica L M van Straaten, Peter H Dijk, Arno van Heijst, Jeroen Dudink, Koen P Dijkman, Monique Rijken, Inge A Zonnenberg, Filip Cools, Alexandra Zecic, Johanna H van der Lee, Debbie H G M Nuytemans, Frank van Bel, Toine C G Egberts, Alwin D R Huitema, PharmaCool study group
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211910 (2019)
ObjectiveMorphine is a commonly used drug in encephalopathic neonates treated with therapeutic hypothermia after perinatal asphyxia. Pharmacokinetics and optimal dosing of morphine in this population are largely unknown. The objective of this study w
Externí odkaz:
https://doaj.org/article/d0c808959dbe4a898084ef6b50bb1751
Autor:
Thomas Alderliesten, Laurent M A Favie, Robert W Neijzen, Volker Auwärter, Cora H A Nijboer, Roland E J Marges, Carin M A Rademaker, Jürgen Kempf, Frank van Bel, Floris Groenendaal
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133818 (2015)
[This corrects the article DOI: 10.1371/journal.pone.0113575.].
Externí odkaz:
https://doaj.org/article/d5becae30cba43b3b40aad6a3bc56fd8
Autor:
Diana A van Riet-Nales, Erwin G A W Römkens, Agnes Saint-Raymond, Piotr Kozarewicz, Alfred F A M Schobben, Toine C G Egberts, Carin M A Rademaker
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98348 (2014)
INTRODUCTION: Pharmaceutical industry is no longer allowed to develop new medicines for use in adults only, as the 2007 Paediatric Regulation requires children to be considered also. The plans for such paediatric development called Paediatric Investi
Externí odkaz:
https://doaj.org/article/aede4028ddd948ac861abdb10be01b24
Autor:
Thomas Alderliesten, Laurent M A Favie, Robert W Neijzen, Volker Auwärter, Cora H A Nijboer, Roland E J Marges, Carin M A Rademaker, Jürgen Kempf, Frank van Bel, Floris Groenendaal
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113575 (2014)
Hypothermia is ineffective in 45% of neonates with hypoxic-ischemic encephalopathy. Xenon has additive neuroprotective properties, but is expensive, and its application complicated. Argon gas is cheaper, easier to apply, and also has neuroprotective
Externí odkaz:
https://doaj.org/article/cc4d6090725a48fdab24691edb51ebf8
Publikováno v:
BMJ Open, Vol 1, Iss 1 (2011)
Background Reported off-label/unlicensed prescribing rates in children range from 11% to 80%. Research into pharmacokinetic profiles of children's medicines is essential in the creation of more knowledge on the safety and efficacy of medicines in chi
Externí odkaz:
https://doaj.org/article/09af1aa27bd544c8967032e248bc035d
Autor:
Marlotte A. A. van der Veer, Timo R. de Haan, Linda G. W. Franken, Caspar J. Hodiamont, Floris Groenendaal, Peter H. Dijk, Willem P. de Boode, Sinno Simons, Koen P. Dijkman, Henrica L. M. van Straaten, Monique Rijken, Filip Cools, Debbie H. G. M. Nuytemans, Anton H. van Kaam, Yuma A. Bijleveld, Ron A. A. Mathôt, Mieke J. Brouwer, Marcel P. van den Broek, Carin M. A. Rademaker, Djien Liem, Katerina Steiner, Sinno H. P. Simons, Annelies A. Bos, S. M. Mulder-de Tollenaer, L. J. M. Groot Jebbink-Akkerman, Michel Sonnaert, Fleur Anne Camfferman
Publikováno v:
Antimicrobial Agents and Chemotherapy, 67, 5
Antimicrobial agents and chemotherapy, 67(5). American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 67
Antimicrobial agents and chemotherapy, 67(5). American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 67
Item does not contain fulltext Ceftazidime is an antibiotic commonly used to treat bacterial infections in term neonates undergoing controlled therapeutic hypothermia (TH) for hypoxic-ischemic encephalopathy after perinatal asphyxia. We aimed to desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c36409b9469e5a370bf44dc11974469
https://repository.ubn.ru.nl/handle/2066/292923
https://repository.ubn.ru.nl/handle/2066/292923
Autor:
Carin M. A. Rademaker, Laurent M A Favié, Cacha Peeters-Scholte, Toine C. G. Egberts, Huibert Tjabbes, Floris Groenendaal, Peter Vis, Frank van Bel, Anouk de Bakker
Publikováno v:
Pediatric Research. NATURE PUBLISHING GROUP
Pediatric Research
Pediatric Research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad7039438cfb2d600f089987b2bddeeb
https://hdl.handle.net/1887/3184317
https://hdl.handle.net/1887/3184317
Autor:
Laurent M A, Favié, Cacha M P C D, Peeters-Scholte, Anouk, Bakker, Huibert, Tjabbes, Toine C G, Egberts, Frank, van Bel, Carin M A, Rademaker, Peter, Vis, Floris, Groenendaal
Publikováno v:
Pediatric research. 88(6)
Autor:
Laurent M A, Favié, Cacha M P C D, Peeters-Scholte, Anouk, Bakker, Huibert, Tjabbes, Toine C G, Egberts, Frank, van Bel, Carin M A, Rademaker, Peter, Vis, Floris, Groenendaal
Publikováno v:
Pediatric research. 87(4)
Neonatal encephalopathy following perinatal asphyxia is a leading cause for neonatal death and disability, despite treatment with therapeutic hypothermia. 2-Iminobiotin is a promising neuroprotective agent additional to therapeutic hypothermia to imp
Autor:
Laurent M. A. Favié, Arlette R. Cox, Agnes van den Hoogen, Cora H. A. Nijboer, Cacha M. P. C. D. Peeters-Scholte, Frank van Bel, Toine C. G. Egberts, Carin M. A. Rademaker, Floris Groenendaal
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
Frontiers in Neurology
Frontiers in Neurology, 9. Frontiers Media S. A.
Frontiers in Neurology, 9
Frontiers in Neurology
Frontiers in Neurology, 9. Frontiers Media S. A.
Frontiers in Neurology, 9
Background: Hypoxic-ischemic encephalopathy following perinatal asphyxia is a leading cause of neonatal death and disability worldwide. Treatment with therapeutic hypothermia reduced adverse outcomes from 60 to 45%. Additional strategies are urgently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d2dd8d65504b64495206ae542888120
https://dspace.library.uu.nl/handle/1874/365148
https://dspace.library.uu.nl/handle/1874/365148